Rankings
▼
Calendar
ITGR (Integer Holdings Corporation) Stock Financials & Earnings | Market Cap Arena
ITGR
Integer Holdings Corporation
Mkt Cap
$3B
Healthcare
·
Medical - Devices
·
🇺🇸 United States
·
NYSE
Revenue (TTM)
$1.9B
Net Income (TTM)
$103M
EPS (TTM)
$2.87
Free Cash Flow (TTM)
$149M
Gross Margin
27.1%
Op. Margin
12.1%
Net Margin
5.5%
FCF Margin
8.1%
P/S Ratio (TTM)
1.6x
P/E Ratio (TTM)
28.8x
YoY Rev Growth
+8.0%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$379M
$97M
$34M
Q2 23
$400M
$93M
$40M
Q3 23
$397M
$105M
$49M
Q4 23
$405M
$110M
$44M
Q1 24
$408M
$109M
$39M
Q2 24
$428M
$118M
$54M
Q3 24
$431M
$117M
$58M
Q4 24
$449M
$117M
$57M
Q1 25
$437M
$121M
$50M
Q2 25
$476M
$131M
$59M
Q3 25
$468M
$126M
$56M
Q4 25
$472M
$125M
$60M
marketcaparena.com
Revenue Breakdown
ITGR
Integer Holdings Corporation
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
2.0x
44.1x
Q2 23
2.0x
42.1x
Q3 23
1.9x
36.3x
Q4 23
1.9x
32.6x
Q1 24
1.8x
30.1x
Q2 24
1.8x
28.1x
Q3 24
1.8x
26.0x
Q4 24
1.7x
24.7x
Q1 25
1.7x
38.4x
Q2 25
1.6x
35.8x
Q3 25
1.6x
34.0x
Q4 25
1.6x
28.8x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$6M
-$19M
Q2 23
$56M
$23M
Q3 23
$62M
$37M
Q4 23
$56M
$19M
Q1 24
$23M
-$6M
Q2 24
$47M
$16M
Q3 24
$72M
$45M
Q4 24
$63M
$44M
Q1 25
$31M
$6M
Q2 25
$44M
$69M
Q3 25
$66M
$46M
Q4 25
$55M
$28M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$25M
Q2 23
$33M
Q3 23
$25M
Q4 23
$37M
Q1 24
$29M
Q2 24
$31M
Q3 24
$26M
Q4 24
$19M
Q1 25
$25M
Q2 25
$25M
Q3 25
$19M
Q4 25
$27M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+21.8%
+19.5%
Q2 23
+14.2%
+13.5%
Q3 23
+15.8%
+11.0%
Q4 23
+8.4%
+9.2%
Q1 24
+7.7%
+7.1%
Q2 24
+7.0%
+3.7%
Q3 24
+8.7%
+7.3%
Q4 24
+11.1%
+8.7%
Q1 25
+7.3%
+5.1%
Q2 25
+11.4%
+11.7%
Q3 25
+8.4%
+10.1%
Q4 25
+5.0%
+5.1%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$6M
1.6%
Q2 23
$6M
1.4%
Q3 23
$5M
1.4%
Q4 23
$6M
1.5%
Q1 24
$7M
1.7%
Q2 24
$6M
1.3%
Q3 24
$6M
1.4%
Q4 24
$6M
1.3%
Q1 25
$7M
1.6%
Q2 25
$6M
1.2%
Q3 25
$5M
1.1%
Q4 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$19M
$42M
Q2 23
$17M
$37M
Q3 23
$14M
$41M
Q4 23
$13M
$45M
Q1 24
$15M
$46M
Q2 24
$16M
$46M
Q3 24
$12M
$44M
Q4 24
$11M
$47M
Q1 25
$14M
$51M
Q2 25
$14M
$52M
Q3 25
$11M
$50M
Q4 25
$10M
$53M
marketcaparena.com
Revenue Segments
Medical Segment
Non-Medical Segment
Cardiac Rhythm Management & Neuromodulation
Cardio And Vascular
Other Markets
Quarter
Medical Segment
Non-Medical Segment
Cardiac Rhythm Management & Neuromodulation
Cardio And Vascular
Other Markets
Q1 23
$364M
$15M
—
—
—
Q2 23
$389M
$11M
—
—
—
Q3 23
$396M
$9M
—
—
—
Q4 23
$404M
$9M
—
—
—
Q1 24
$407M
$8M
—
—
—
Q2 24
$427M
$9M
—
—
—
Q3 24
—
—
$165M
$241M
$25M
Q1 25
—
—
$160M
$259M
$18M
Q2 25
—
—
$172M
$287M
$18M
Q3 25
—
—
$169M
$277M
$21M
Q4 25
—
—
$167M
$284M
$21M
marketcaparena.com
Revenue by Geography
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$41M
$0
$41M
Q2 23
$39M
$0
$39M
Q3 23
$32M
$0
$32M
Q4 23
$24M
$0
$24M
Q1 24
$42M
$0
$42M
Q2 24
$34M
$0
$34M
Q3 24
$36M
$0
$36M
Q4 24
$47M
$0
$47M
Q1 25
$32M
$0
$32M
Q2 25
$23M
$0
$23M
Q3 25
$59M
$0
$59M
Q4 25
$17M
$0
$17M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
34M
+0.4%
Q2 23
34M
+0.3%
Q3 23
34M
+0.3%
Q4 23
34M
+0.6%
Q1 24
35M
+3.0%
Q2 24
36M
+1.5%
Q3 24
36M
+0.7%
Q4 24
36M
+1.3%
Q1 25
34M
-6.4%
Q2 25
36M
+5.3%
Q3 25
36M
-0.3%
Q4 25
35M
-1.3%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$203K
3K
FY 15
$217K
4K
FY 16
$114K
9K
FY 17
$117K
10K
FY 18
$147K
8K
FY 19
$152K
8K
FY 20
$143K
8K
FY 21
$136K
9K
FY 22
$133K
10K
FY 23
$148K
11K
FY 24
$156K
11K
FY 25
$169K
11K
marketcaparena.com